Matt Hancock giving Downing Street coronavirus press briefing

The transcript discusses the vaccine supply and deployment plans, focusing on the NHS's role in ensuring timely vaccination for vulnerable groups. It highlights uncertainties in regulatory approval and manufacturing, with a focus on Pfizer and AstraZeneca vaccines. The bulk of the rollout is expected in the new year, with a timeline for vulnerable groups set by JCVI.

What is the main factor that the vaccination plan depends on?

• Government funding

• Weather conditions

• Supply availability

• Public demand

By when is it suggested that vulnerable groups will be accessed for vaccination?

• End of February

• End of January

• End of April

• End of March

What are the two leading vaccine candidates mentioned?

• Novavax and CureVac

• Sinovac and Sputnik V

• Pfizer-BioNTech and AstraZeneca-Oxford

• Moderna and Johnson & Johnson

What is the NHS's role in the vaccination process?

• Manufacturing the vaccine

• Funding the vaccine research

• Regulating the vaccine

• Leading the deployment of the vaccine

When is the bulk of the vaccine rollout expected to occur?

• In the new year

• By the end of the current year

• In two years

• By mid-next year